Queen's University Belfast
New Institute Launches With £55M to Fuel Precision Medicine R&D in Northern Ireland
The new Future Medicines Institute, based at Queen's University Belfast, is backed by government and industry.
Northern Ireland-Based Cancer Dx Firm GenoMe Diagnostics Raises £1.4M
The Queen's University Belfast spinout plans to develop a blood test called OvaMe for the early detection of ovarian cancer.
The test relies on a signature that Almac developed for stratifying breast cancer patients, but which, as the researchers showed, can be used in other cancers as well.